Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Suven Life Sciences Q1...

    Suven Life Sciences Q1 net up 58.1% at Rs 32.57 cr

    Written by savita thakur thakur Published On 2016-08-12T14:17:20+05:30  |  Updated On 12 Aug 2016 2:17 PM IST
    Suven Life Sciences Q1 net up 58.1% at Rs 32.57 cr

    Suven Life Sciences reported a 58.1 percent increase in net profit to Rs 32.57 crore for the first quarter ended June 30, 2016.


    The company had posted a net profit of Rs 20.6 crore in the same quarter last fiscal, Suven Life Sciences said in a BSE filing.


    Net sales during the quarter under review stood at Rs 133.22 crore, as against Rs 101.17 crore in the corresponding period, up 31.68 percent, it added.


    The contract research and manufacturing services vertical had a revenue of Rs 127.66 crore during the quarter, as against Rs 95.9 crore in the year-ago period.


    During the period, the company secured 11 product patents covering India, South Africa, Israel, Mexico, Canada, Hong Kong, Europe, Eurasia, Macau and New Zealand, it added.


    The company said that its thrust on innovative R&D in drug discovery continues with a spending of Rs 14.7 crore in the first quarter of the ongoing fiscal.

    BSEnet profitpatentsSuven Life Sciences
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok